ETFs

Every Korean-listed ETF: size, money in and out, and how far the price sits from the fund's net asset value.

Clear16 funds
FundAUMvs NAV
KoAct Bio Healthcare Active462900 · Biotech (new drugs) · −1.71%₩294B−0.34%
TIGER Bio TOP 10364970 · Biotech (new drugs) · −0.91%₩246B−0.34%
TIME K Bio Active463050 · Biotech (new drugs) · −1.75%₩205B−0.67%
KODEX Bio244580 · Biotech (new drugs) · −1.41%₩196B−0.09%
TIGER Healthcare143860 · Biotech (new drugs) · −0.50%₩131B−0.09%
TIGER Technology Transfer Bio Active0168K0 · Biotech (new drugs) · −1.31%₩102B−0.12%
KODEX Healthcare266420 · Biotech (new drugs) · −1.32%₩63B−0.58%
TIGER KOSDAQ 150 Biotech261070 · Biotech (new drugs) · −1.53%₩47B+0.22%
RISE Bio TOP10 Active0000Z0 · Biotech (new drugs) · −1.15%₩41B+0.06%
TIGER 200 Health Care227540 · Biotech (new drugs) · +0.40%₩28B+0.30%
HANARO Bio Korea Active498050 · Biotech (new drugs) · −1.64%₩8.3B−0.20%
MIDAS Bio Healthcare Active0214M0 · Biotech (new drugs) · −1.69%₩7.2B−1.02%
ACE K Bio KOSDAQ Active0221Z0 · Biotech (new drugs) · −1.71%₩7.1B−0.52%
RISE Healthcare253280 · Biotech (new drugs) · −0.92%₩6.8B−0.24%
MIGHTY New Drug Focus Bio Active0229F0 · Biotech (new drugs) · −2.31%₩5B+0.36%
UNICORN K Bio Active0184V0 · Biotech (new drugs) · −2.53%₩4.2B−0.24%

Closing data for Oct 29, 2026. Flows are new or redeemed shares × NAV. Premium/discount = closing price vs NAV.